Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Iloprost for Lung Cancer Prevention in High-Risk Patients
NCT00084409Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2001
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost in lung cancer, sponsored by University of Colorado Denver. Started Nov 2001; status: completed.
02
Drugs
iloprost
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00084409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084409.